MedPath

Neomycin and Polymyxin B Sulfates and Bacitracin Zinc

Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment USP

Approved
Approval ID

65b71a14-dcb5-4123-b4c5-033c9e16a22a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-192
Application NumberANDA064064
Product Classification
M
Marketing Category
C73584
G
Generic Name
Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMarch 30, 2007
FDA Product Classification

INGREDIENTS (5)

Neomycin SulfateActive
Quantity: 3.5 mg in 1 g
Code: 057Y626693
Classification: ACTIB
Polymyxin B SulfateActive
Quantity: 10000 mg in 1 g
Code: 19371312D4
Classification: ACTIB
Bacitracin ZincActive
Quantity: 400 ug in 1 g
Code: 89Y4M234ES
Classification: ACTIB
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Neomycin and Polymyxin B Sulfates and Bacitracin Zinc - FDA Drug Approval Details